Evidence map›Paper›PMID 29749547›Full record

ArticleMolecular medicine reports2018

Salidroside inhibits the proliferation and migration of gastric cancer cells via suppression of Src‑associated signaling pathway activation and heat shock protein 70 expression.

Zhilin Qi, Tuo Tang, Lili Sheng, Yunfei Ma, Yinhua Liu, Liang Yan, Shimei Qi, Liefeng Ling, Yao Zhang

Open access · hybridAbstract read
In one paragraph

Article in Molecular medicine reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. The EPMA journal · 2024
    Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Prevention of High Glucose-Mediated EMT by Inhibition of Hsp70 Chaperone.International journal of molecular sciences · 2021
    Article
  11. Article
  12. Article
  13. Advances in Research on Anticancer Properties of Salidroside.Chinese journal of integrative medicine · 2021
    Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Research Progress ofIntegrative cancer therapies
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Zhilin QiDepartment of Biochemistry, Wannan Medical College, Wuhu, Anhui 241002, P.R. China.
Tuo TangAnhui Province Key Laboratory of Active Biological Macromolecules, Wannan Medical College, Wuhu, Anhui 241002, P.R. China.
Lili ShengDepartment of Oncology, Yijishan Hospital, Wannan Medical College, Wuhu, Anhui 241002, P.R. China.
Yunfei MaAnhui Province Key Laboratory of Active Biological Macromolecules, Wannan Medical College, Wuhu, Anhui 241002, P.R. China.
Yinhua LiuDepartment of Pathology, Yijishan Hospital, Wannan Medical College, Wuhu, Anhui 241002, P.R. China.
Liang YanDepartment of Biochemistry, Wannan Medical College, Wuhu, Anhui 241002, P.R. China.
Shimei QiDepartment of Biochemistry, Wannan Medical College, Wuhu, Anhui 241002, P.R. China.
Liefeng LingDepartment of Biochemistry, Wannan Medical College, Wuhu, Anhui 241002, P.R. China.
Yao ZhangDepartment of Biochemistry, Wannan Medical College, Wuhu, Anhui 241002, P.R. China.
Wannan Medical College · CNFirst Affiliated Hospital of Wannan Medical College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Salidroside, an active ingredient extracted from the Rhodiola rosea plant, has potential anti‑tumor effects. However, the effects of salidroside on gastric cancer cell proliferation and migration remain unclear. In the present study, the inhibitory effects of salidroside on gastric cancer cell proliferation, migration and invasion and the molecular mechanisms underlying these effects were investigated. The human gastric cancer cell line, BGC‑823, was treated with different concentrations of salidroside (200, 400 and 600 µg/ml). Cell proliferation was determined with Cell Counting Kit‑8 and colony formation assays, and the migration and invasion of cells was detected by a wound healing and Transwell assay, respectively. Western blotting was performed to detect the levels of N‑cadherin, E‑cadherin and heat shock protein (HSP)70. In addition, the phosphorylation of proto‑oncogene tyrosine‑protein kinase Src (Src), protein kinase B (Akt), mitogen activated protein kinase 1 (ERK), signal transducer and activator of transcription (STAT)3 and focal adhesion kinase 1 (FAK) was examined by western blotting. The levels of matrix metalloproteinase (MMP)‑2 and MMP‑9 were determined by enzyme‑linked immunosorbent assay kits. Levels of reactive oxygen species (ROS) in cells were measured by a fluorescence plate reader with dichloro‑dihydro‑fluorescein diacetate. The results indicated that salidroside significantly suppressed cell proliferation and colony formation, inhibited cell migration and invasion, increased E‑cadherin expression and decreased N‑cadherin, MMP‑2 and MMP‑9 expression. Furthermore, salidroside suppressed ROS production and subsequently reduced the phosphorylation of Src, Akt, ERK and FAK. Salidroside also inhibited HSP70 expression, and HSP70 overexpression reversed the inhibitory effects of salidroside on BGC‑823 cell proliferation, migration and invasion. In conclusion, the present study revealed that salidroside inhibited the proliferation, migration and invasion of BGC‑823 cells by downregulating ROS‑mediated Src‑associated signaling pathway activation and HSP70 expression.

Indexed as

Cell Line, TumorCell MovementCell ProliferationGene Expression Regulation, NeoplasticGlucosidesHSP70 Heat-Shock ProteinsHumansNeoplasm ProteinsPhenolsSignal Transductionsrc-Family KinasesStomach NeoplasmsGlucosidesHSP70 Heat-Shock ProteinsNeoplasm ProteinsPhenolsrhodiolosidesrc-Family Kinases

Identifiers

PMID29749547
PMCPMC6059663
OpenAlexW2800201817

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.